NewsOGI caught my interest today that they are moving on THCV which I have posted about as a new sku line of cannabinoids that could be exciting because it's purposeful intent is to curb appetites.
Some of the Big Pharma guys have flirted with this but it is a fringe line that could be profitable for somebody, maybe OGI.
The fat burning section of the drug store has a lot of shelfspace and their nr got lost to the biggies today on the rescheduling news.
That calorie and sugar problem of alcohol offerings is what tweaked me onto the investment potential of cannabis infused beverages cannibalizing beer and light alcohol sales.
Tilray and Canopy are all over these but need some new rules such that they can compete in the same venues as alcohol. I don't know if rescheduling would fix that issue but there is a tiger waiting to get loose there.
glta and dyodd